美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

信息服务

4.12

-0.1400-3.29%

盘后：4.120.00000.00%16:55 EDT

成交量：16.93万

成交额：69.72万

市值：1.97亿

市盈率：19.62

高：4.26

开：4.26

低：4.06

收：4.26

52周最高：6.45

52周最低：3.74

股本：4,788.41万

流通股本：3,498.93万

量比：0.88

换手率：0.48%

股息：0.18

股息率：4.37%

每股收益(TTM):0.2100

每股收益(LYR):0.1900

净资产收益率：11.17%

总资产收益率：5.99%

市净率：2.09

市盈率(LYR):21.68

数据加载中...

总览公司新闻公告

“缠腰龙”剧痛无解？全球首款mRNA带状疱疹疫苗开启万人临床；全球首个双抗ADC将展开HR+/HER2-乳腺癌III期临床研究 | 掘金创新药

每日经济新闻

新股首日 | 麦科医药-B(02335)首挂上市早盘高开86.92% 核心产品MT1013正处于III期临床阶段

轩竹生物-B(02575)：安奈拉唑钠新适应症根除幽门螺杆菌之III期临床试验完成首例患者入组

【券商聚焦】西南证券：英硅智能(03696)核心管线III期临床启动若成功上市有望成颠覆性疗法

规范股票、基金、理财等数据分类分级多部门联合印发《金融信息服务数据分类分级指南》

中证金牛座

六部门联合发布！事关金融信息服务数据分类分级

《金融信息服务数据分类分级指南》印发

40亿美元买来的AI药物，III期头对头打败BMS，预计明年上市！

和黄医药(00013)于2026年欧洲血液学协会年会公布索乐匹尼布用于治疗温抗体型自身免疫性溶血性贫血的ESLIM-02研究III期数据

天辰生物-B(01779)：LP-003针对季节性过敏性鼻炎适应症的III期临床试验达到主要终点

港股异动 | 康宁杰瑞制药-B(09966)涨超6% 恩尼妥®一线治疗HER2阳性晚期乳腺癌III期临床研究达到主要终点

石药集团(01093)：安尼妥单抗(KN026)联合注射用多西他赛(白蛋白结合型)(HB1801)用于HER2阳性晚期乳腺癌一线治疗的III期研究达到主要终点

赛诺菲(SNY.US)再遭研发重挫：罕见病新药III期试验失败后叫停，新CEO承压

富达国民信息服务公司(FIS)盘前涨1.59% 联合Fuse推出针对美加汽车贷款传统痛点的解决方案

百利天恒(688506.SH)：BL-M14D1(DLL3ADC)联合免疫治疗用于一线广泛期小细胞肺癌患者的III期临床试验申请获得FDA许可

智通财经网

G-III上调2027财年盈利预期，目标Marc Jacobs长期营收10亿美元

环球市场播报

ST万邦(002082.SZ)：石杉碱甲控释片II/III期临床试验完成200例受试者入组

依托成熟毒素平台百利天恒BL-M05D1胃癌III期试验完成首例入组

复宏汉霖H药III期临床研究数据登顶《柳叶刀》与ASCO 开创胃癌围术期“去化疗”新范式

中国网财经

Karyopharm将邀专家解读骨髓纤维化III期SENTRY试验结果

环球市场播报

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/III/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服务","latestPrice":4.12,"timestamp":1785441600000,"preClose":4.26,"halted":0,"volume":169333,"hourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"16:55 EDT","volume":3676,"amount":15145.12,"timestamp":1785444924376,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03286384976525814,"floatShares":34989300,"shares":47884104,"eps":0.209971,"marketStatus":"盘后交易","change":-0.14,"latestTime":"07-30 18:44:01 EDT","open":4.255,"high":4.255,"low":4.06,"amount":697245.4761335,"amplitude":0.045775,"askPrice":4.55,"askSize":1000,"bidPrice":3.9,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.209971,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785456000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":4.26,"dividendRate":0.043689,"preHourTrading":{"tag":"盘前","latestPrice":4.19,"preClose":4.26,"latestTime":"09:29 EDT","volume":136,"amount":574.3400088,"timestamp":1785418141106,"change":-0.07,"changeRate":-0.016432,"amplitude":0.049296},"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"16:55 EDT","volume":3676,"amount":15145.12,"timestamp":1785444924376,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.879885,"impliedVol":1.7448,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34989300,"roa":"5.99%","roe":"11.17%","lyrEps":0.19,"volumeRatio":0.879885,"shares":47884104,"dividePrice":0.18,"high":4.255,"amplitude":0.045775,"preClose":4.26,"low":4.06,"week52Low":3.74,"pbRate":"2.09","psRate":"0.80","week52High":6.4495,"institutionHeld":0.6684,"latestPrice":4.12,"committee":-0.998002,"eps":0.209971,"divideRate":0.043689,"volume":169333,"delay":0,"ttmEps":0.209971,"open":4.255,"prevYearClose":5.78,"prevWeekClose":3.86,"prevMonthClose":4.11,"prevQuarterClose":4.11,"fiveDayClose":3.84,"twentyDayClose":4.19,"sixtyDayClose":4.12,"earningDate":1785859200000,"earningTime":"盘后","dividendPayoutRate":0.9280598907982862,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.03333720106347336},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2026-08-05","symbol":"III","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0.06,"defaultRemindTime":1785960000000,"name":null,"time":"盘后","dateTimestamp":1785902400000,"actualEps":null},{"date":"2026-06-05","symbol":"III","amount":0.045,"announcedDate":"2026-05-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-05","defaultRemindTime":1780666200000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-05","currency":"USD","dateTimestamp":1780632000000,"payDate":"2026-06-26"},{"market":"US","date":"2026-05-07","symbol":"III","fiscalQuarterEnding":"2026/03","expectedEps":0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":0.06},{"date":"2026-03-20","symbol":"III","amount":0.045,"announcedDate":"2026-03-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-26"},{"market":"US","date":"2026-03-05","symbol":"III","fiscalQuarterEnding":"2025/12","expectedEps":0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2026-07-29","current":19.574132,"percent":0.521987,"low":-221.876594,"twenty":12.58915,"median":18.223516,"eighty":29.572197,"high":68.328883,"avg":1.104082,"sd":58.997004,"marketCap":198532987},"quantilePoints":[{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-16","current":29.987043,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":231380025},{"date":"2025-05-23","current":29.29984,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":226077566},{"date":"2025-05-30","current":29.237367,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":225595524},{"date":"2025-06-06","current":29.424786,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":227041650},{"date":"2025-06-13","current":29.862097,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":230415942},{"date":"2025-06-20","current":29.612205,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":228487775},{"date":"2025-06-27","current":28.862529,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":222703274},{"date":"2025-07-03","current":31.923706,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":246323318},{"date":"2025-07-11","current":31.486395,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":242949026},{"date":"2025-07-18","current":29.237367,"twenty":12.58915,"median":18.866214,"eighty":34.89521,"marketCap":225595524},{"date":"2025-07-25","current":28.425218,"twenty":12.58915,"median":18.866214,"eighty":34.834126,"marketCap":219328982},{"date":"2025-08-01","current":26.925866,"twenty":12.58915,"median":18.866214,"eighty":34.784891,"marketCap":207759981},{"date":"2025-08-08","current":25.754678,"twenty":12.58915,"median":18.866214,"eighty":34.77297,"marketCap":202457522},{"date":"2025-08-15","current":30.470866,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":239531480},{"date":"2025-08-22","current":29.489913,"twenty":12.58915,"median":18.866214,"eighty":34.221243,"marketCap":231820205},{"date":"2025-08-29","current":31.39051,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":246760801},{"date":"2025-09-05","current":32.432773,"twenty":12.58915,"median":18.85295,"eighty":34.118522,"marketCap":254954031},{"date":"2025-09-12","current":32.126225,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":252544257},{"date":"2025-09-19","current":33.965513,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":267002898},{"date":"2025-09-26","current":35.314324,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":277605901},{"date":"2025-10-03","current":34.639918,"twenty":12.58915,"median":18.866214,"eighty":34.639918,"marketCap":272304399},{"date":"2025-10-10","current":33.842894,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":266038988},{"date":"2025-10-17","current":33.413727,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":262665306},{"date":"2025-10-24","current":34.088132,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":267966807},{"date":"2025-10-31","current":33.536346,"twenty":12.58915,"median":18.866214,"eighty":34.748399,"marketCap":263629215},{"date":"2025-11-07","current":28.380485,"twenty":12.58915,"median":18.866214,"eighty":34.701228,"marketCap":277248962},{"date":"2025-11-14","current":25.733601,"twenty":12.58915,"median":18.866214,"eighty":34.517299,"marketCap":251391546},{"date":"2025-11-21","current":24.557208,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":239899361},{"date":"2025-11-28","current":26.370814,"twenty":12.58915,"median":18.866214,"eighty":34.210751,"marketCap":257616479},{"date":"2025-12-05","current":28.282453,"twenty":12.58915,"median":18.866214,"eighty":33.965513,"marketCap":276291280},{"date":"2025-12-12","current":29.409829,"twenty":12.58915,"median":18.866214,"eighty":33.842894,"marketCap":287304624},{"date":"2025-12-19","current":29.26278,"twenty":12.58915,"median":18.866214,"eighty":33.529773,"marketCap":285868100},{"date":"2025-12-26","current":29.066715,"twenty":12.58915,"median":18.866214,"eighty":33.430508,"marketCap":283952736},{"date":"2026-01-02","current":28.331469,"twenty":12.58915,"median":18.866214,"eighty":33.342648,"marketCap":276770121},{"date":"2026-01-09","current":29.164747,"twenty":12.58915,"median":18.866214,"eighty":33.210859,"marketCap":284910418},{"date":"2026-01-16","current":29.80196,"twenty":12.58915,"median":18.866214,"eighty":33.054432,"marketCap":291135352},{"date":"2026-01-23","current":27.792289,"twenty":12.58915,"median":18.866214,"eighty":32.903351,"marketCap":271502869},{"date":"2026-01-30","current":27.400158,"twenty":12.58915,"median":18.866214,"eighty":32.739321,"marketCap":267672141},{"date":"2026-02-06","current":24.998355,"twenty":12.58915,"median":18.866214,"eighty":32.548436,"marketCap":244208930},{"date":"2026-02-13","current":22.35147,"twenty":12.58915,"median":18.866214,"eighty":32.359621,"marketCap":218351514},{"date":"2026-02-20","current":22.841634,"twenty":12.58915,"median":18.866214,"eighty":32.126225,"marketCap":223139924},{"date":"2026-02-27","current":23.429831,"twenty":12.58915,"median":18.866214,"eighty":32.068687,"marketCap":228886017},{"date":"2026-03-06","current":24.400849,"twenty":12.58915,"median":18.866214,"eighty":31.936898,"marketCap":227928335},{"date":"2026-03-13","current":20.466129,"twenty":12.58915,"median":18.866214,"eighty":31.809821,"marketCap":191174107},{"date":"2026-03-20","current":19.649525,"twenty":12.58915,"median":18.866214,"eighty":31.731279,"marketCap":183546212},{"date":"2026-03-27","current":19.7516,"twenty":12.58915,"median":18.866214,"eighty":31.635749,"marketCap":184499699},{"date":"2026-04-02","current":19.598487,"twenty":12.58915,"median":18.866214,"eighty":31.486395,"marketCap":183069469},{"date":"2026-04-10","current":20.415091,"twenty":12.58915,"median":18.866214,"eighty":31.417108,"marketCap":190697364},{"date":"2026-04-17","current":21.282732,"twenty":12.58915,"median":18.866214,"eighty":31.338565,"marketCap":198802001},{"date":"2026-04-24","current":20.466129,"twenty":12.58915,"median":18.866214,"eighty":31.102233,"marketCap":191174107},{"date":"2026-05-01","current":20.823393,"twenty":12.58915,"median":18.866214,"eighty":30.970444,"marketCap":194511311},{"date":"2026-05-08","current":18.809916,"twenty":12.58915,"median":18.839687,"eighty":30.838724,"marketCap":198802001},{"date":"2026-05-15","current":19.2371,"twenty":12.58915,"median":18.809916,"eighty":30.611773,"marketCap":203316914},{"date":"2026-05-22","current":19.780266,"twenty":12.58915,"median":18.739199,"eighty":30.409557,"marketCap":209057627},{"date":"2026-05-29","current":20.504486,"twenty":12.58915,"median":18.718829,"eighty":30.267569,"marketCap":216711911},{"date":"2026-06-05","current":19.644474,"twenty":12.58915,"median":18.739199,"eighty":30.174462,"marketCap":207622449},{"date":"2026-06-12","current":19.372892,"twenty":12.58915,"median":18.739199,"eighty":30.111989,"marketCap":204752092},{"date":"2026-06-18","current":18.829726,"twenty":12.58915,"median":18.698459,"eighty":29.987245,"marketCap":199011379},{"date":"2026-06-26","current":18.377089,"twenty":12.58915,"median":18.492688,"eighty":29.953208,"marketCap":194227452},{"date":"2026-07-02","current":18.965518,"twenty":12.58915,"median":18.492688,"eighty":29.862097,"marketCap":200446558},{"date":"2026-07-10","current":18.422353,"twenty":12.58915,"median":18.42051,"eighty":29.749013,"marketCap":194705845},{"date":"2026-07-17","current":18.558144,"twenty":12.58915,"median":18.377089,"eighty":29.67784,"marketCap":196141023},{"date":"2026-07-24","current":17.381286,"twenty":12.58915,"median":18.28067,"eighty":29.612205,"marketCap":183702812},{"date":"2026-07-29","current":18.784463,"twenty":12.58915,"median":18.223516,"eighty":29.572197,"marketCap":198532987}],"updateTime":1785441174196},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645816545","title":"“缠腰龙”剧痛无解？全球首款mRNA带状疱疹疫苗开启万人临床；全球首个双抗ADC将展开HR+/HER2-乳腺癌III期临床研究 | 掘金创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2645816545","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645816545?lang=zh_cn&edition=fundamental","pubTime":"2026-06-24 21:24","pubTimestamp":1782307495,"startTime":"0","endTime":"0","summary":"资本眼一周行情上周（6月15日至21日），医药生物指数下跌1.48%，跑输上证指数2.94个百分点。创新药（BK1106）周内下跌0.90%；恒生医疗保健业指数（HSCICH）周内下跌1.83%；港股创新药ETF广发（513120）周内下跌1.97%。机构观点中邮证券我们探讨高潜力特异性皮炎（AD）市场的下一个方向：口服+新作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243781663812.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243781663812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK4225","ADC","159646","06978","BK4080","III","BK4134","BK1161","BK4231","BK4203","HR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645697863","title":"新股首日 | 麦科医药-B(02335)首挂上市 早盘高开86.92% 核心产品MT1013正处于III期临床阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2645697863","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645697863?lang=zh_cn&edition=fundamental","pubTime":"2026-06-24 09:25","pubTimestamp":1782264328,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，麦科医药-B首挂上市，公告显示，每股定价18.2港元，共发行5805.44万股股份，每手200股，所得款项净额约10.67亿港元。截至发稿，涨86.92%，报34.02港元，成交额2.17亿港元。公开资料显示，麦科医药已自主开发由一项核心产品及其他六项候选产品组成的产品管线。预计公司的MT1013将于2028年初商业化，公司将实行双轨商业化策略：在国内透过与第三方合约销售组织合作，在国际上则透过授权合作伙伴关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","IPOS","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645097981","title":"轩竹生物-B(02575)：安奈拉唑钠新适应症根除幽门螺杆菌之III期临床试验完成首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2645097981","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645097981?lang=zh_cn&edition=fundamental","pubTime":"2026-06-21 18:11","pubTimestamp":1782036715,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B 发布公告，团自主研发的创新药安奈拉唑钠肠溶片用于含安奈拉唑钠的铋剂四联疗法根除幽门螺杆菌之III期临床研究，近日已成功完成首例患者入组，标志着该项关键注册临床研究正式迈入实质性执行阶段。本次Hp根除适应症III期临床研究于2026年4月获中国国家药品监督管理局药品审评中心批准开展后，迅速完成首例患者入组，充分彰显公司临床开发团队的高效执行能力，亦标志该项目正式进入临床执行关键阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","02575","BK1191","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644777227","title":"【券商聚焦】西南证券：英硅智能(03696)核心管线III期临床启动 若成功上市有望成颠覆性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2644777227","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644777227?lang=zh_cn&edition=fundamental","pubTime":"2026-06-18 14:22","pubTimestamp":1781763776,"startTime":"0","endTime":"0","summary":"金吾财讯 | 西南证券发布研报指，英硅智能 于2026年6月13日召开核心管线Rentosertib用于治疗特发性肺纤维化的III期临床试验研究者会议。Rentosertib是全球首款完全由生成式AI发现并完成IIa期临床的候选药物。若成功上市，有望成为颠覆性疗法。主要风险包括创新药研发和商业化不及预期、竞争加剧、行业政策变化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984105","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK4134","BK1141","BK0183","03696","BK0276","BK0028","BK0188","600369","III","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643209286","title":"规范股票、基金、理财等数据分类分级 多部门联合印发《金融信息服务数据分类分级指南》","url":"https://stock-news.laohu8.com/highlight/detail?id=2643209286","media":"中证金牛座","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643209286?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 21:54","pubTimestamp":1781531640,"startTime":"0","endTime":"0","summary":"据中国网信网消息，为指导金融信息服务机构开展数据分类分级和重要数据识别工作，提升金融信息服务数据安全水平，依据相关法律法规规章和政策规定，国家互联网信息办公室、中国人民银行、国家金融监督管理总局、中国证券监督管理委员会、国家统计局、国家外汇管理局近日联合印发《金融信息服务数据分类分级指南》。《指南》明确了股票、债券、基金、外汇、商品、理财、指数数据等的分类分级安排。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/bank/bank_hydt/2026-06-15/doc-inicpewh9815133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","159940","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643229019","title":"六部门联合发布！事关金融信息服务数据分类分级","url":"https://stock-news.laohu8.com/highlight/detail?id=2643229019","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643229019?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 10:55","pubTimestamp":1781492100,"startTime":"0","endTime":"0","summary":"　　6月13日，国家互联网信息办公室、中国人民银行、金融监管总局等六部门发布《金融信息服务数据分类分级指南》。　　《指南》根据金融信息服务数据在经济社会发展中的重要程度和敏感程度等维度，将其从高到低分为四级，分别为核心数据、重要数据、敏感一般数据、常规一般数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/bank/bank_yhfg/2026-06-15/doc-inicnckv0036371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159940","BK4134","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643410211","title":"《金融信息服务数据分类分级指南》印发","url":"https://stock-news.laohu8.com/highlight/detail?id=2643410211","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643410211?lang=zh_cn&edition=fundamental","pubTime":"2026-06-13 16:09","pubTimestamp":1781338140,"startTime":"0","endTime":"0","summary":"新京报讯 据网信中国消息，近日，国家互联网信息办公室、中国人民银行、国家金融监督管理总局、中国证券监督管理委员会、国家统计局、国家外汇管理局联合印发《金融信息服务数据分类分级指南》。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2026/06/10/5728863546402481147.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/06/10/5728863546402481147.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1781337300129025.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1781337300129025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["III","BK4134","159940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642264255","title":"40亿美元买来的AI药物，III期头对头打败BMS，预计明年上市！","url":"https://stock-news.laohu8.com/highlight/detail?id=2642264255","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642264255?lang=zh_cn&edition=fundamental","pubTime":"2026-06-12 18:03","pubTimestamp":1781258580,"startTime":"0","endTime":"0","summary":"一款AI药物，III期实验成功！昨晚，武田公布了这款TYK2药物的最新III期临床信息。数据显示，该药物头对头疗效直接完胜BMS同靶点药物Sotyktu！武田计划在2027年上半年，将zasocitinib正式推向市场。由此，Sotyktu成为全球首款获批上市的TYK2抑制剂。目前该药物已经以1亿元首付款成功对外授权。这是中国率先由AI辅助设计、进入III期确证性临床的小分子药物。III期试验计划在中国招募约750名超重或肥胖受试者，进行52周评估，预计2028年底或2029年上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-12/doc-iniccwvp3522336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","BMS","IPOS","CHAT","AIPO","III","AGIX","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642258314","title":"和黄医药(00013)于2026年欧洲血液学协会年会公布索乐匹尼布用于治疗温抗体型自身免疫性溶血性贫血的ESLIM-02研究III期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2642258314","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642258314?lang=zh_cn&edition=fundamental","pubTime":"2026-06-12 08:18","pubTimestamp":1781223487,"startTime":"0","endTime":"0","summary":"基于ESLIM-02研究的数据，索乐匹尼布用于治疗既往对至少一种糖皮质激素治疗反应不佳的成人温抗体型自身免疫性溶血性贫血的患者的新药上市申请已于2026年4月获中国国家药品监督管理局受理，并获纳入优先审评。此外，索乐匹尼布组的溶血指标较安慰剂组亦出现改善，显示活动性溶血减轻。索乐匹尼布显示出良好的安全性。索乐匹尼布组未有TEAE相关的死亡或治疗中断报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4588","BK4531","BK4134","BK1587","BK4585","00013","HCM","BK1588","BK1191","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642237531","title":"天辰生物-B(01779)：LP-003针对季节性过敏性鼻炎适应症的III期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2642237531","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642237531?lang=zh_cn&edition=fundamental","pubTime":"2026-06-12 06:16","pubTimestamp":1781216203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天辰生物-B 发布公告，LP-003针对季节性过敏性鼻炎的III期临床试验已达到预先设定的主要终点，且该等结果在统计学及临床方面均具有高度重要性。LP-003针对季节性过敏性鼻炎适应症的III期临床试验是一项在中国开展的多中心、随机、双盲、安慰剂对照的III期临床研究，旨在比较LP-003与安慰剂治疗经标准治疗控制不佳的中重度季节性过敏性鼻炎的效果。主要排除标准为患有季节性过敏性鼻炎以外的合并症的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","01779","III"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2642709854","title":"港股异动 | 康宁杰瑞制药-B(09966)涨超6% 恩尼妥®一线治疗HER2阳性晚期乳腺癌III期临床研究达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2642709854","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642709854?lang=zh_cn&edition=fundamental","pubTime":"2026-06-11 09:44","pubTimestamp":1781142289,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康宁杰瑞制药-B涨超6%，截至发稿，涨4.22%，报6.92港元，成交额515.34万港元。消息面上，6月10日，康宁杰瑞制药-B发布公告，与石药集团附属公司上海津曼特生物科技有限公司合作开发的安尼妥单抗联合注射用多西他赛用于人类表皮生长因子受体2阳性晚期乳腺癌一线治疗的III期临床研究，经独立数据监察委员会评估，成功达到预先设定的主要终点无进展生存期，结果具有显著的统计学和临床双重意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0326950275.SGD","LU1960683339.HKD","BK4585","BK1161","LU0501845795.SGD","LU0880133367.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1226287529.USD","LU1226287875.USD","LU1813983027.USD","LU1807302812.USD","LU1152091168.USD","BK1574","LU2039709279.SGD","IE00B5MMRT66.SGD","IE0008369823.USD","LU0072913022.USD","LU1008478684.HKD","LU1226288253.USD","LU0315179316.USD","01093","LU1951186391.HKD","LU1993786604.SGD","BK1521","IE00BZ08YT58.USD","IE00B031HY20.USD","III","VXUS","BK4134","LU1226287792.SGD","IE0008368742.USD","LU0140636845.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU1226288170.HKD","BK4588","LU1152091754.HKD","LU1328277881.USD","09966","LU0314109678.HKD","LU0067412154.USD","BK1191","HK0000165453.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428162","title":"石药集团(01093)：安尼妥单抗(KN026)联合注射用多西他赛(白蛋白结合型)(HB1801)用于HER2阳性晚期乳腺癌一线治疗的III期研究达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428162","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642428162?lang=zh_cn&edition=fundamental","pubTime":"2026-06-10 19:04","pubTimestamp":1781089458,"startTime":"0","endTime":"0","summary":"曲妥珠单抗联合帕妥珠单抗和多西他赛目前仍是国内外HER2阳性晚期乳腺癌一线治疗的首选方案。安尼妥单抗注射液新辅助治疗HER2阳性乳腺癌的III期临床研究亦已达到主要终点，并将于近期进行新药上市申请申报。此外，安尼妥单抗注射液针对HER2阳性乳腺癌的辅助治疗和HER2阳性胃癌的一线治疗等多项临床研究正在进行中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1813983027.USD","IE00BZ08YT58.USD","LU0880133367.SGD","BK4134","HK0000165453.HKD","IE00B543WZ88.USD","LU0315179316.USD","LU1807302812.USD","III","LU1226288253.USD","LU1226287792.SGD","LU1960683339.HKD","LU0067412154.USD","IE0008369823.USD","BK1521","01093","LU1152091754.HKD","IE00B5MMRT66.SGD","SG9999004220.SGD","LU2039709279.SGD","LU1008478684.HKD","LU0314109678.HKD","LU0072913022.USD","LU0140636845.USD","LU0326950275.SGD","LU1152091168.USD","LU1993786604.SGD","BK1191","LU0501845795.SGD","IE00B031HY20.USD","BK1515","IE0008368742.USD","LU1226287529.USD","LU1226288170.HKD","LU1226287875.USD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1328277881.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642462904","title":"赛诺菲(SNY.US)再遭研发重挫：罕见病新药III期试验失败后叫停，新CEO承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2642462904","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642462904?lang=zh_cn&edition=fundamental","pubTime":"2026-06-10 16:16","pubTimestamp":1781079372,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，法国制药巨头赛诺菲周三宣布，因一项针对罕见自身免疫疾病的实验性药物在后期临床试验中未能显示出有效性，公司将提前终止该研究。CIDP是一种罕见的自身免疫疾病，患者会出现四肢进行性无力及感觉障碍，严重影响生活质量。研发接连遇挫，新CEO“内忧外患”加里是在今年2月临危受命的。然而，此次试验失败并非孤立事件。随着riliprubart的III期失败，市场对赛诺菲研发能力的信心恐进一步受到考验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","IE00BFXG1179.USD","BK4007","III","BK4585","BK4588","SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641820344","title":"富达国民信息服务公司(FIS)盘前涨1.59% 联合Fuse推出针对美加汽车贷款传统痛点的解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2641820344","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641820344?lang=zh_cn&edition=fundamental","pubTime":"2026-06-08 21:20","pubTimestamp":1780924829,"startTime":"0","endTime":"0","summary":"金吾财讯 | 富达国民信息服务公司 盘前小幅走高，最新报41.60美元，涨幅1.59%，盘前成交额1.92亿美元。消息面上，该公司新近宣布已与云原生贷款解决方案提供商 Fuse 达成战略联盟。双方将针对美国和加拿大市场的间接汽车及设备贷款机构，联合推出一套现代化的端到端贷款发放解决方案，旨在解决传统系统决策滞后、人工承保繁琐等痛点，帮助贷款机构在激烈的市场竞争中赢回份额。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NmJhNzAzYmFlYjJhNGNmZDhhMTE1NWJmMTYxODM5M2UxMzU2NDM2MDM2MQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301278","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","LU2279689827.SGD","FIS","LU1823568750.SGD","LU2347655156.SGD","BK4588","LU1267930227.SGD","LU0726765562.USD","LU0795875169.SGD","LU0310800965.SGD","BK4581","LU0128525689.USD","LU1732800096.USD","III","LU1861217088.USD","BK4227","LU0661504455.SGD","LU2347655073.USD","LU0052756011.USD","LU0738911758.USD","LU0912757837.SGD","LU0949170772.SGD","LU1046421795.USD","LU1732799900.SGD","BK4585","LU0006061336.USD","LU2360107671.USD","LU0162691827.USD","LU0077335932.USD","LU0795875086.SGD","LU1668664300.SGD","LU0072461881.USD","LU2133065610.SGD","BK4106","LU1861220207.SGD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641045171","title":"百利天恒(688506.SH)：BL-M14D1(DLL3ADC)联合免疫治疗用于一线广泛期小细胞肺癌患者的III期临床试验申请获得FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2641045171","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641045171?lang=zh_cn&edition=fundamental","pubTime":"2026-06-08 15:36","pubTimestamp":1780904174,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒 发布公告，公司的全资子公司 SystImmune,Inc.近日收到美国食品药品监督管理局的通知， BL-M14D1联合免疫治疗用于一线广泛期小细胞肺癌患者的III期临床试验申请已获得FDA许可。BL-M14D1与iza-bren 共享同一小分子技术平台，公司拥有其完整的全球权益。本次BL-M14D1的III期临床研究获得FDA的IND许可，将进一步推进公司业务和产品国际化布局的进程，对公司近期业绩不会产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LABU","688506","BK4585","BK4588","91194","III","LU0757428866.USD","02615","BK0239","BK4023","BL","BK4134","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641142720","title":"G-III上调2027财年盈利预期，目标Marc Jacobs长期营收10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641142720","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641142720?lang=zh_cn&edition=fundamental","pubTime":"2026-06-06 03:23","pubTimestamp":1780687380,"startTime":"0","endTime":"0","summary":"G-III服装集团周五公布2027财年第一季度业绩，同时上调全年盈利指引。公司预计2027财年非GAAP每股收益将在2.15至2.25美元区间，高于此前预测的2.00至2.10美元。此外，公司设定了Marc Jacobs品牌长期年营收达到10亿美元的目标。毛利率大幅扩张2270个基点至近65%，其中包含1.027亿美元的关税回收收益。Goldfarb进一步指出，Marc Jacobs品牌长期年营收有望达到10亿美元。　　G-III预计Marc Jacobs交易将于2027财年第三季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-06/doc-iniamanc1204252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641484110","title":"ST万邦(002082.SZ)：石杉碱甲控释片II/III期临床试验完成200例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484110","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484110?lang=zh_cn&edition=fundamental","pubTime":"2026-06-05 19:45","pubTimestamp":1780659900,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST万邦(002082.SZ)发布公告，公司全资子公司万邦德制药集团有限公司的2.2类新药石杉碱甲控释片用于治疗轻、中度阿尔茨海默病型痴呆的II/III期关键注册临床试验，于近日完成200例受试者入组。公司积极推进受试者入组，将继续与首都医科大学宣武医院等全国50多家研究机构紧密合作，进一步验证药物的安全性、有效性，为产品的最终上市申请提供关键数据支撑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","002082","III","BK0050","BK4134","BK0004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640197152","title":"依托成熟毒素平台 百利天恒BL-M05D1胃癌III期试验完成首例入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2640197152","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640197152?lang=zh_cn&edition=fundamental","pubTime":"2026-06-04 19:52","pubTimestamp":1780573920,"startTime":"0","endTime":"0","summary":"6月4日，百利天恒（688506）发布公告，公司自主研发的创新生物药注射用BL-M05D1（Claudin18.2ADC）用于在既往经一线治疗的Claudin18.2阳性晚期胃癌或胃食管结合部腺癌的III期临床试验已完成首例受试者入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606043760581427.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606043760581427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02615","BK4023","BK4134","688506","III","91194","LU1815336091.USD","BK0239","BL","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911801","title":"复宏汉霖H药III期临床研究数据登顶《柳叶刀》与ASCO 开创胃癌围术期“去化疗”新范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911801","media":"中国网财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640911801?lang=zh_cn&edition=fundamental","pubTime":"2026-06-02 17:30","pubTimestamp":1780392638,"startTime":"0","endTime":"0","summary":"中国网财经6月2日讯复宏汉霖(2696.HK)今日宣布，公司自主研发的创新型抗PD-1单抗H药汉斯状?(斯鲁利单抗)用于胃癌新辅助/辅助治疗的III期临床研究(ASTRUM-006)数据，在2026年美国临床肿瘤学会(ASCO)年会以口头报告的形式首次正式发布，并同步在线发表于国际顶尖医学期刊《柳叶刀》，斩获国际两大顶级学术平台权威认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606023757635031.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606023757635031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02696","HK0000165453.HKD","BK4134","BK1161","HK0000306685.HKD","HK0000320223.HKD","HK0000320264.USD","III","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640968887","title":"Karyopharm将邀专家解读骨髓纤维化III期SENTRY试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2640968887","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640968887?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 22:44","pubTimestamp":1780325040,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc．今日宣布，将于美国东部时间6月2日下午2：00召开投资者电话会议，详细解读selinexor联合ruxolitinib治疗骨髓纤维化的III期SENTRY试验结果。会议将在Mascarenhas博士于2026年美国临床肿瘤学会年会上口头报告试验结果之后举行。　　Karyopharm计划与美国食品药品监督管理局讨论整体数据及潜在补充新药申请事宜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-01/doc-inhzxmef5076533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["III","BK4134"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":3,"totalSize":166,"code":"91000000","status":"200"}]}}